Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 302
Ph III recruiting: 41
Growth YoY: +2.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 251–257 of 257 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00165464	Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer	completed	Phase 2	54	Dana-Farber Cancer InstituteOTHER	1	Apr 28, 2009	clinicaltrials
NCT00215462	Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma	completed	Phase 2	32	Dana-Farber Cancer InstituteOTHER	1	Apr 28, 2009	clinicaltrials